(1) Gatekeeper potentially Failed UNVC investors in 2021--The Attorney Letter!!!
In 2021, the Attorney Opinion Letter served as the primary filter for "Pink Current" status.
Attorney Donald R. Keer was the signatory. Under OTC Rules, an attorney must perform "due diligence," which includes interviewing management and reviewing public records. If Keer never done full Due Diligence or relied on David Dalton checking the NONE-BOX
If Case CV-2019-008314 (the fraud lawsuit/settlement, also the 3 unsettled judgements in MD) was omitted (they were)from the July 2021 filing, the letter may be considered "false or misleading."
2026 The "Management Certification" regulatory shift is significant. Unlike the 2021 rules, the current 2026 standard places the "Duty of Candor" squarely on the CEO. David Dalton, By signing a (M-C), the CEO affirms under penalty of perjury that all legal proceedings and material risks are disclosed.
The Half-Truth-In the eyes of the SEC, telling part of the story to induce investment while hiding the "risk" part is equivalent to a direct lie.
The Reality--When a corporation’s charter is forfeited (as has been the case with Univec in Maryland), the directors become trustees of the assets. Their sole legal mandate is to pay off creditors and distribute remaining assets to stockholders. Promoting a "new AI platform" or seeking "mergers" while in a state of forfeiture is a violation of this trustee duty.
The CPA listed in filings, Richard Hill Blickstein’s license revocation (PA001161L) remains a matter of public record. Any financial statements associated with revoked professionals are generally considered "unreliable" by OTC Markets compliance.
"The issuer is utilizing a forfeited corporate shell (MD File #F07298094) to promote high-tech narratives (AI/Genetics) while failing to disclose a 2020 fraud settlement (Case 2019-008314) and over $15 million in senior liabilities. This creates a fraudulent 'half-truth' environment where retail investors provide liquidity for debt-to-equity conversions, unaware that the CEO's legal mandate under Maryland law is liquidation, not expansion."
The issuer is utilizing a 'double-blind' disclosure strategy to mislead the public. They list a revoked CPA (Richard Blickstein, PA #PA001161L) to provide a false sense of financial legitimacy, while simultaneously using a non-certified advisor (Jorge Schcolnik/Consultia) to prepare disclosure statements that omit over $300,000 in senior government judgments and a prior fraud settlement. CEO David Dalton then personally certified these known omissions in his March 3, 2026, Management Certification filing—while the corporation itself remains in a state of Forfeiture."
In Section 7 of the 2021 OTC filings which included 2019 thur to the March 2026 filings, CEO David Dalton checked 'NONE' regarding pending legal proceedings. This is a verifiable falsehood. In the PA Fraud Case (Case # CV-2019-008314]), the presiding judge recently denied management’s motion to dismiss, finding sufficient evidence to move the fraud claims forward to trial. Under OTC Disclosure Rules, a pending fraud trial is a 'Material Legal Proceeding' that MUST be disclosed. By checking 'NONE,' management has effectively bypassed the primary safety mechanism designed to protect retail investors."
Disclaimer-Not advice to buy or sell:
PL
In 2021, the Attorney Opinion Letter served as the primary filter for "Pink Current" status.
Attorney Donald R. Keer was the signatory. Under OTC Rules, an attorney must perform "due diligence," which includes interviewing management and reviewing public records. If Keer never done full Due Diligence or relied on David Dalton checking the NONE-BOX
If Case CV-2019-008314 (the fraud lawsuit/settlement, also the 3 unsettled judgements in MD) was omitted (they were)from the July 2021 filing, the letter may be considered "false or misleading."
2026 The "Management Certification" regulatory shift is significant. Unlike the 2021 rules, the current 2026 standard places the "Duty of Candor" squarely on the CEO. David Dalton, By signing a (M-C), the CEO affirms under penalty of perjury that all legal proceedings and material risks are disclosed.
The Half-Truth-In the eyes of the SEC, telling part of the story to induce investment while hiding the "risk" part is equivalent to a direct lie.
The Reality--When a corporation’s charter is forfeited (as has been the case with Univec in Maryland), the directors become trustees of the assets. Their sole legal mandate is to pay off creditors and distribute remaining assets to stockholders. Promoting a "new AI platform" or seeking "mergers" while in a state of forfeiture is a violation of this trustee duty.
The CPA listed in filings, Richard Hill Blickstein’s license revocation (PA001161L) remains a matter of public record. Any financial statements associated with revoked professionals are generally considered "unreliable" by OTC Markets compliance.
"The issuer is utilizing a forfeited corporate shell (MD File #F07298094) to promote high-tech narratives (AI/Genetics) while failing to disclose a 2020 fraud settlement (Case 2019-008314) and over $15 million in senior liabilities. This creates a fraudulent 'half-truth' environment where retail investors provide liquidity for debt-to-equity conversions, unaware that the CEO's legal mandate under Maryland law is liquidation, not expansion."
The issuer is utilizing a 'double-blind' disclosure strategy to mislead the public. They list a revoked CPA (Richard Blickstein, PA #PA001161L) to provide a false sense of financial legitimacy, while simultaneously using a non-certified advisor (Jorge Schcolnik/Consultia) to prepare disclosure statements that omit over $300,000 in senior government judgments and a prior fraud settlement. CEO David Dalton then personally certified these known omissions in his March 3, 2026, Management Certification filing—while the corporation itself remains in a state of Forfeiture."
In Section 7 of the 2021 OTC filings which included 2019 thur to the March 2026 filings, CEO David Dalton checked 'NONE' regarding pending legal proceedings. This is a verifiable falsehood. In the PA Fraud Case (Case # CV-2019-008314]), the presiding judge recently denied management’s motion to dismiss, finding sufficient evidence to move the fraud claims forward to trial. Under OTC Disclosure Rules, a pending fraud trial is a 'Material Legal Proceeding' that MUST be disclosed. By checking 'NONE,' management has effectively bypassed the primary safety mechanism designed to protect retail investors."
Disclaimer-Not advice to buy or sell:
PL
1
